Kymera Therapeutics
Latest round
- Series C
Last raised
- Mar 2020
Total raised
- $193M
Investors
- 17
About Kymera Therapeutics
Based in Massachusetts, US, and founded in 2016, Kymera Therapeutics, Inc. operates as a biotechnology company that develops therapeutics for cancer, autoimmune diseases, and inflammatory diseases. The company was founded by President and CEO Dr. Nello Mainolfi. In December 2025, Kymera Therapeutics, Inc.00 per share on the Nasdaq Global Select Market under the ticker symbol KYMR. Kymera Therapeutics is a biopharmaceutical company that focuses on advancing the field of targeted protein degradation by accessing the body’s innate protein recycling machinery to degrade dysregulated, disease-causing proteins to address previously intractable disease targets. The company’s Pegasus™ platform enables the discovery of novel small molecule degraders designed to harness the body’s natural protein recycling machinery to degrade disease-causing proteins, with a focus on undrugged nodes invalidated pathways currently inaccessible with therapeutics. Kymera Therapeutics’s initial programs are IRAK4, IRAKIMiD, and STAT3, each of which addresses impact targets within the IL-1R/TLR or JAK/STAT pathways, providing the opportunity to treat immune-inflammatory diseases, hematologic malignancies, and solid tumors.
Who invested in Kymera Therapeutics
17 investors across 3 rounds
See all investors in Kymera Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Kymera Therapeutics
Who invested in Kymera Therapeutics?
Kymera Therapeutics has 17 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kymera Therapeutics raised?
Kymera Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Kymera Therapeutics last raise money?
Kymera Therapeutics's most recent round on record is a Series C, in Mar 2020.
What does Kymera Therapeutics do?
Based in Massachusetts, US, and founded in 2016, Kymera Therapeutics, Inc.
Where is Kymera Therapeutics headquartered?
Kymera Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Kymera Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kymera Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Kymera Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.